MYCIO Wealth Partners’s MOLECULAR INSIGHT PHARMACEUTICALS, INC.COM STK MIPI Stock Holding History

MYCIO Wealth Partners’s Portfolio MIPI Stock Details MIPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-12,500	Closed	–	–	821
2016 Q3	$0	Hold	12,500	–	–	﹤0.01%	1178
2016 Q2	$0	Hold	12,500	–	–	﹤0.01%	1200
2016 Q1	$0	Hold	12,500	–	–	﹤0.01%	948
2015 Q4	$0	Hold	12,500	–	–	﹤0.01%	951
2015 Q3	$0	Hold	12,500	–	–	﹤0.01%	988
2015 Q2	$0	Buy	+12,500	New	–	﹤0.01%	758

MYCIO Wealth Partners's MIPI Position: Q4 2016 in Review

MYCIO Wealth Partners sold out of MOLECULAR INSIGHT PHARMACEUTICALS, INC.COM STK (MIPI) in Q4 2016, closing a stake of 12,500 shares.

MYCIO Wealth Partners first reported a position in MIPI in Q2 2015 and held it in 6 quarters. The position peaked at $0 in Q3 2016. 0 funds tracked by Wall St. Rank hold MIPI as of Q4 2016.

MYCIO Wealth Partners reported no remaining MOLECULAR INSIGHT PHARMACEUTICALS, INC.COM STK position as of Q4 2016 after selling out during the quarter.
MYCIO Wealth Partners sold 12,500 MOLECULAR INSIGHT PHARMACEUTICALS, INC.COM STK shares in Q4 2016.
MYCIO Wealth Partners first reported a position in MOLECULAR INSIGHT PHARMACEUTICALS, INC.COM STK in Q2 2015 and held it in 6 quarters.
MYCIO Wealth Partners's MOLECULAR INSIGHT PHARMACEUTICALS, INC.COM STK position peaked at $0 in Q3 2016.
0 funds tracked by Wall St. Rank held MOLECULAR INSIGHT PHARMACEUTICALS, INC.COM STK as of Q4 2016.

Based on MYCIO Wealth Partners's 13F filing for Q4 2016, filed 1 Feb 2017.